Skip to main content
SpringerLink
Log in

The interpretation of trials: Combined hormonal therapy and chemotherapy in disseminated breast cancer

  • US-Japan Conference on Chemoendocrine Therapy
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Glick JH, Creech RH, Torri S, Holroyde C, Brodovsky H, Catalano RB, Varano M: Tamoxifen plus sequential CMF chemotherapy versus tamoxifen alone in postmenopausal patients with advanced breast cancer. Cancer 45: 735–741, 1981.

    Google Scholar 

  2. Cavalli F, Alberto P, Jungi F, Brunner K, Martz G: Hormono-chemotherapy followed by chemotherapy in the treatment of disseminated breast cancer.In Mouridsen HT and Palshef T (eds): Breast Cancer — Experimental and Clinical Aspects. Pergamon Press, 1980, pp 125–129.

Download references

Author information

Authors and Affiliations

  1. Northern California Cancer Program, P.O. Box 10144, 94303, Palo Alto, CA, USA

    Stephen K. Carter M.D.

Authors
  1. Stephen K. Carter M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carter, S.K. The interpretation of trials: Combined hormonal therapy and chemotherapy in disseminated breast cancer. Breast Cancer Res Tr 1, 43–51 (1981). https://doi.org/10.1007/BF01807891

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01807891

Keywords

Search

Navigation